Effects of Folic Acid Consumption on Newborn Defects and Miscarriage, and Content Uniformity Analysis of Three Different Brands of Folic Acid Tablets Dosage Forms
Keywords:Folic acid, Anti-oxidant, Newborn defects, Miscarriage
There is a recent rise in the number of birth defects. This could be related to folic acid deficiency. Folic acid, as an antioxidant, is an important factor in preventing birth defects during embryonic development. This study, via content uniformity measurements and medical history, aimed to investigate the role of folic acid before and during pregnancy and to measure the content uniformity of different brands of folic acid tablets. The statistical study aimed to determine the relationship between folic acid consumption, miscarriage, and anomalies in newborn babies. The study studied a sample of 300 women based on their medical records. There was no significant effect (p-value = 0.143) of folic acid consumption on the frequency of anomalies. On the other hand, there was a high significant relation (p-value = 0.003) between folic acid consumption and miscarriage. The correlation, principally with miscarriage, coincides with previous studies and highlights the importance of folic acid supplementation before and during gestation. Content uniformity measurements were made on three famous folic acid brands (Folic Acid-Nile, Folicum-Julphar and Wockhardt-UK) available at local pharmacies. Measurements on the three folic acid brands were conducted in compliance with the British Pharmacopoeia (BP) (2010) test for content uniformity. Ten tablets from each brand were tested using the UV spectrophotometric method. The results showed that only the first brand name passed the content uniformity test, while the other two brands did not comply with the standards. This result highlights the problem of under-dosing in commercially available folic acid dosage forms, and identifies the need for taking action towards the implementation of quality control on all medical drugs.
Ahn, E., Nava-Ocampo, A. A., & Koren, G. (2004). Multivitamin supplements for pregnant women. New insights. Canadian family physician, 50(5), 705-706.
Al-Mashhadane, F. A., Al-Mashhadane, A. A., & Taqa, A. A. R. (2018). Folic Acid Supplementation: A Review of the Known Advantages and Risks.
Andres, J., Evans, J., & Royle, C. (2008). Prevalence of congenital anomalies. Canadian Perinatal Health Report, 158-163.
Bower, C., & Stanley, F. J. (1989). Dietary folate as a risk factor for neural‐tube defects: evidence from a case‐control study in Western Australia. Medical Journal of Australia, 150(11), 613-619. DOI: https://doi.org/10.5694/j.1326-5377.1989.tb136723.x
Brown, J. E., Jacobs, D. R., Hartman, T. J., Barosso, G. M., Stang, J. S., Gross, M. D., & Zeuske, M. A. (1997). Predictors of red cell folate level in women attempting pregnancy. Jama, 277(7), 548-552. DOI: https://doi.org/10.1001/jama.277.7.548
Czeizel, A., Dudás, I., Vereczkey, A., & Bánhidy, F. (2013). Folate deficiency and folic acid supplementation: the prevention of neural-tube defects and congenital heart defects. Nutrients, 5(11), 4760-4775. DOI: https://doi.org/10.3390/nu5114760
Đuriš, J., Čalija, B., Vidović, B., Dobričić, V., Milić, J., & Ibrić, S. (2017). Comparative analysis of mechanical and dissolution properties of single-and multicomponent folic acid supplements. Journal of Food Composition and Analysis, 60, 17-24. DOI: https://doi.org/10.1016/j.jfca.2017.03.005
French, A. E., Grant, R., Weitzman, S., Ray, J. G., Vermeulen, M. J., Sung, L., Greenberg, M., & Koren, G. (2003). Folic acid food fortification is associated with a decline in neuroblastoma. Clinical Pharmacology & Therapeutics, 74(3), 288-294. DOI: https://doi.org/10.1016/S0009-9236(03)00200-5
Goh, Y. I., Bollano, E., Einarson, T. R., & Koren, G. (2006). Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. Journal of obstetrics and gynaecology Canada, 28(8), 680-689. DOI: https://doi.org/10.1016/S1701-2163(16)32227-7
Green, N. S. (2002). Folic acid supplementation and prevention of birth defects. The Journal of nutrition, 132(8), 2356S-2360S. DOI: https://doi.org/10.1093/jn/132.8.2356S
Hibbard, B. M. (1965). The role of folic acid in pregnancy with particular reference to anaemia, abruption and abortion. Obstetrical & Gynecological Survey, 20(1), 35-39. DOI: https://doi.org/10.1097/00006254-196502000-00009
Matias, R., Ribeiro, P., Sarraguça, M., & Lopes, J. (2014). A UV spectrophotometric method for the determination of folic acid in pharmaceutical tablets and dissolution tests. Analytical Methods, 6(9), 3065-3071. DOI: https://doi.org/10.1039/c3ay41874j
McStay, C., Prescott, S., Bower, C., & Palmer, D. (2017). Maternal folic acid supplementation during pregnancy and childhood allergic disease outcomes: a question of timing? Nutrients, 9(2), 123. DOI: https://doi.org/10.3390/nu9020123
Pharmacopoeia, B. (2010). Vol. 1, The Department of Health. British Pharmacopoeia Commission, London, 1, 219-222.
Pulikkunnel, S. T., & Thomas, S. (2005). Neural tube defects: pathogenesis and folate metabolism. JAPI, 53, 127-135.
Ribeiro, M. V. d. M., Melo, I. d. S., Lopes, F. d. C. d. C., & Moita, G. C. (2016). Development and validation of a method for the determination of folic acid in different pharmaceutical formulations using derivative spectrophotometry. Brazilian Journal of Pharmaceutical Sciences, 52(4), 741-750. DOI: https://doi.org/10.1590/s1984-82502016000400019
Smithells, R., Sheppard, S., & Schorah, C. (1976). Vitamin dificiencies and neural tube defects. Archives of disease in childhood, 51(12), 944-950. DOI: https://doi.org/10.1136/adc.51.12.944
Smithells, R., Sheppard, S., Schorah, C., Seller, M., Nevin, N., Harris, R., Read, A., & Fielding, D. (1980). Possible prevention of neural-tube defects by periconceptional vitamin supplementation. The Lancet, 315(8164), 339-340. DOI: https://doi.org/10.1016/S0140-6736(80)90886-7
Wald, N., Law, M., Morris, J., & Wald, D. (2001). Quantifying the effect of folic acid. The Lancet, 358(9298), 2069-2073 DOI: https://doi.org/10.1016/S0140-6736(01)07104-5
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of the articles Published by Almukhtar Journal of Science (MJSc) is retained by the author(s), who grant MJSc a license to publish the article. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors and cite MJSc as original publisher. Also they accept the article remains published by MJSc website (except in occasion of a retraction of the article).